Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protirelin dose-finding study in prolonged critical illness with non-thyroidal illness syndrome
NL-OMON46988Phase 2Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of thyrotropin-releasing hormone in euthyroid sick syndrome (NTIS) (4 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in T3 concentration. Planned start Aug 2016; status: withdrawn.
02
Drugs
thyrotropin-releasing hormone
03
Conditions
euthyroid sick syndrome (NTIS)
Beyond the preview
Go deeper on NL-OMON46988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46988.